ICON plc , (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the publication and filing of a circular to shareholders convening an extraordinary general meeting to be held at 3.00 p.m. on December 17, 2012 at ICON plc Headquarters, South County Business Park, Leopardstown, Dublin 18, Ireland at which resolutions in connection with the proposed replacement of ICON’s NASDAQ listing for ADSs with a direct NASDAQ listing for ICON Shares will be considered and voted on.
The expected timetable in respect of the proposals is as follows:
|Latest time and date for receipt of Forms of Proxy for Ordinary Shareholders for Extraordinary General Meeting||
13 December 2012
(6 p.m. GMT)
|Extraordinary General Meeting||17 December 2012 (3 p.m. GMT)|
|Expected last day of dealings in Shares on Irish Stock Exchange||29 January 2013|
Expected date of Irish Stock Exchange Delisting with effect from 6.30 a.m. (GMT)
|30 January 2013|
|Expected date of commencement of direct trading of Shares on NASDAQ||4 February 2013|
A copy of the Circular is available in the investor relations section of ICON’s website at http://investor.iconplc.com/proxy.cfm.
A copy of the Circular is also being submitted to the Irish Stock Exchange, and will shortly be available for inspection at: